NCT06179888 2026-03-18
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
Institut Bergonié
Mayo Clinic
Mayo Clinic
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center